84 related articles for article (PubMed ID: 21936563)
21. Over-expression of hTERT in CHO K1 results in decreased apoptosis and reduced serum dependency.
Crea F; Sarti D; Falciani F; Al-Rubeai M
J Biotechnol; 2006 Jan; 121(2):109-23. PubMed ID: 16144725
[TBL] [Abstract][Full Text] [Related]
22. Expression and distribution of human telomerase catalytic component, hTERT, in human breast tissues.
Yano Y; Yoshida K; Osaki A; Toge T; Tahara H; Ide T; Yasui W
Anticancer Res; 2002; 22(6C):4101-7. PubMed ID: 12553039
[TBL] [Abstract][Full Text] [Related]
23. Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor.
Wu P; Meng L; Wang H; Zhou J; Xu G; Wang S; Xi L; Chen G; Wang B; Zhu T; Lu Y; Ma D
Biochem Biophys Res Commun; 2005 Sep; 335(1):36-44. PubMed ID: 16051188
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells.
Kondoh K; Tsuji N; Asanuma K; Kobayashi D; Watanabe N
Exp Cell Res; 2007 Oct; 313(16):3486-96. PubMed ID: 17706193
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis of U937 human leukemic cells by sodium butyrate is associated with inhibition of telomerase activity.
Choi YH
Int J Oncol; 2006 Nov; 29(5):1207-13. PubMed ID: 17016653
[TBL] [Abstract][Full Text] [Related]
26. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells.
Takakura M; Kyo S; Kanaya T; Hirano H; Takeda J; Yutsudo M; Inoue M
Cancer Res; 1999 Feb; 59(3):551-7. PubMed ID: 9973199
[TBL] [Abstract][Full Text] [Related]
27. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T
Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial localization of telomerase as a determinant for hydrogen peroxide-induced mitochondrial DNA damage and apoptosis.
Santos JH; Meyer JN; Van Houten B
Hum Mol Genet; 2006 Jun; 15(11):1757-68. PubMed ID: 16613901
[TBL] [Abstract][Full Text] [Related]
29. Specific inhibition of caspase-3 by a competitive DARPin: molecular mimicry between native and designed inhibitors.
Schroeder T; Barandun J; Flütsch A; Briand C; Mittl PR; Grütter MG
Structure; 2013 Feb; 21(2):277-89. PubMed ID: 23333429
[TBL] [Abstract][Full Text] [Related]
30. C-terminal regions of the human telomerase catalytic subunit essential for in vivo enzyme activity.
Banik SS; Guo C; Smith AC; Margolis SS; Richardson DA; Tirado CA; Counter CM
Mol Cell Biol; 2002 Sep; 22(17):6234-46. PubMed ID: 12167716
[TBL] [Abstract][Full Text] [Related]
31. Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors.
Akiyama M; Yamada O; Kanda N; Akita S; Kawano T; Ohno T; Mizoguchi H; Eto Y; Anderson KC; Yamada H
Cancer Lett; 2002 Apr; 178(2):187-97. PubMed ID: 11867204
[TBL] [Abstract][Full Text] [Related]
32. Modulation of telomerase activity and human telomerase reverse transcriptase expression by caspases and bcl-2 family proteins in Cisplatin-induced cell death.
Park YP; Choi SC; Cho MY; Song EY; Kim JW; Paik SG; Kim YK; Kim JW; Lee HG
Korean J Lab Med; 2006 Aug; 26(4):287-93. PubMed ID: 18156740
[TBL] [Abstract][Full Text] [Related]
33. Telomerase confers resistance to caspase-mediated apoptosis.
Bermudez Y; Erasso D; Johnson NC; Alfonso MY; Lowell NE; Kruk PA
Clin Interv Aging; 2006; 1(2):155-67. PubMed ID: 18044112
[TBL] [Abstract][Full Text] [Related]
34. Identification of human telomerase assembly inhibitors enabled by a novel method to produce hTERT.
Kellermann G; Kaiser M; Dingli F; Lahuna O; Naud-Martin D; Mahuteau-Betzer F; Loew D; Ségal-Bendirdjian E; Teulade-Fichou MP; Bombard S
Nucleic Acids Res; 2015 Sep; 43(15):e99. PubMed ID: 25958399
[TBL] [Abstract][Full Text] [Related]
35. Specificity of a protein-protein interface: local dynamics direct substrate recognition of effector caspases.
Fuchs JE; von Grafenstein S; Huber RG; Wallnoefer HG; Liedl KR
Proteins; 2014 Apr; 82(4):546-55. PubMed ID: 24085488
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the lamprey genotype provides insights into caspase evolution and functional divergence.
Liu Y; Xu X; Wang X; Zhu T; Li J; Pang Y; Li Q
Mol Immunol; 2021 Apr; 132():8-20. PubMed ID: 33524772
[TBL] [Abstract][Full Text] [Related]
37. Cacidases: caspases can cleave after aspartate, glutamate and phosphoserine residues.
Seaman JE; Julien O; Lee PS; Rettenmaier TJ; Thomsen ND; Wells JA
Cell Death Differ; 2016 Oct; 23(10):1717-26. PubMed ID: 27367566
[TBL] [Abstract][Full Text] [Related]
38. Targeting to the endoplasmic reticulum improves the folding of recombinant human telomerase reverse transcriptase.
Wu CK; Gousset K; Hughes SH
Protein Expr Purif; 2007 Nov; 56(1):8-19. PubMed ID: 17658270
[TBL] [Abstract][Full Text] [Related]
39. Molecular determinants involved in activation of caspase 7.
Boucher D; Blais V; Drag M; Denault JB
Biosci Rep; 2011 Aug; 31(4):283-94. PubMed ID: 20942802
[TBL] [Abstract][Full Text] [Related]
40. Selective detection of caspase-3 versus caspase-7 using activity-based probes with key unnatural amino acids.
Vickers CJ; González-Páez GE; Wolan DW
ACS Chem Biol; 2013 Jul; 8(7):1558-66. PubMed ID: 23614665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
